<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>GOALI: Experimental and Theoretical Studies on Compaction with Application on Pharmaceutical Powders</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>07/15/2001</AwardEffectiveDate>
<AwardExpirationDate>06/30/2005</AwardExpirationDate>
<AwardTotalIntnAmount>269776.00</AwardTotalIntnAmount>
<AwardAmount>279776</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07030000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>CMMI</Abbreviation>
<LongName>Div Of Civil, Mechanical, &amp; Manufact Inn</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Ken Chong</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>CMS-0100063&lt;br/&gt;EXPERIMENTAL AND THEORETICAL STUDIES ON COMPACTION WITH APPLICATION ON&lt;br/&gt;PHARMACEUTICAL POWDERS&lt;br/&gt;Antonios Zavaliangos and Iosif Csaba Sinka&lt;br/&gt;GOALI - NSF/CMS&lt;br/&gt;&lt;br/&gt;In contrast to the scientific advances in drug design, tablet processing has&lt;br/&gt;been dominated by empiricism, and it presents a bottleneck for transition to&lt;br/&gt;market of new discoveries.  In this basic research project, Drexel&lt;br/&gt;University and Merck &amp; Co., Inc. aim to develop a science basis for the&lt;br/&gt;compaction of pharmaceutical powders that leads to solid dosages. Specific&lt;br/&gt;objectives of this study are to: (i) establish experimental procedures for&lt;br/&gt;characterization of pharmaceutical powders under conditions characteristic&lt;br/&gt;of industrial operations. (ii) determine experimentally the origin of rate&lt;br/&gt;effects and their influence on the mechanical properties of tablets, (iii)&lt;br/&gt;formulate constitutive models that portray accurately the behavior of powder&lt;br/&gt;mixtures during compaction, (iv) develop design guidelines that will allow&lt;br/&gt;rational decision making in pharmaceutical powder formulation.&lt;br/&gt;&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>07/18/2001</MinAmdLetterDate>
<MaxAmdLetterDate>02/17/2004</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0100063</AwardID>
<Investigator>
<FirstName>Antonios</FirstName>
<LastName>Zavaliangos</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Antonios Zavaliangos</PI_FULL_NAME>
<EmailAddress>azavalia@coe.drexel.edu</EmailAddress>
<PI_PHON>2158952078</PI_PHON>
<NSF_ID>000178499</NSF_ID>
<StartDate>07/18/2001</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Csaba</FirstName>
<LastName>Sinka</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Csaba Sinka</PI_FULL_NAME>
<EmailAddress>csaba_sinka@merck.com</EmailAddress>
<PI_PHON>2158952000</PI_PHON>
<NSF_ID>000226890</NSF_ID>
<StartDate>07/18/2001</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Drexel University</Name>
<CityName>Philadelphia</CityName>
<ZipCode>191021119</ZipCode>
<PhoneNumber>2158956342</PhoneNumber>
<StreetAddress>1505 Race St, 10th Floor</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Pennsylvania</StateName>
<StateCode>PA</StateCode>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>PA03</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>002604817</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>DREXEL UNIVERSITY</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>002604817</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[Drexel University]]></Name>
<CityName>Philadelphia</CityName>
<StateCode>PA</StateCode>
<ZipCode>191021119</ZipCode>
<StreetAddress><![CDATA[1505 Race St, 10th Floor]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Pennsylvania</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>PA03</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0106000</Code>
<Name>Materials Research</Name>
</FoaInformation>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>1504</Code>
<Text>GOALI-Grnt Opp Acad Lia wIndus</Text>
</ProgramElement>
<ProgramElement>
<Code>1630</Code>
<Text>Mechanics of Materials and Str</Text>
</ProgramElement>
<ProgramReference>
<Code>1504</Code>
<Text>GRANT OPP FOR ACAD LIA W/INDUS</Text>
</ProgramReference>
<ProgramReference>
<Code>9161</Code>
<Text>SINGLE DIVISION/UNIVERSITY</Text>
</ProgramReference>
<ProgramReference>
<Code>9231</Code>
<Text>SUPPL FOR UNDERGRAD RES ASSIST</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>AMPP</Code>
<Text>ADVANCED MATERIALS &amp; PROCESSING PROGRAM</Text>
</ProgramReference>
<Appropriation>
<Code>0101</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0104</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2001~269776</FUND_OBLG>
<FUND_OBLG>2004~10000</FUND_OBLG>
</Award>
</rootTag>
